Quick Answer
NEOGENOMICS INC reported Operating Income of -$115.88 million for fiscal year 2025.
NEOGENOMICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$115.88M | -25.8% |
| 2024 | -$92.11M | +14.5% |
| 2023 | -$107.74M | +31.6% |
| 2022 | -$157.62M | -32.7% |
| 2021 | -$118.75M | -748.7% |
| 2020 | -$13.99M | -207.6% |
| 2019 | $13.01M | +29.5% |
| 2018 | $10.04M | +246.0% |
| 2017 | $2.90M | +34.7% |
| 2016 | $2.15M | +138.2% |
| 2015 | -$5.63M | -354.1% |
| 2014 | $2.22M | -30.1% |
| 2013 | $3.17M | +162.1% |
| 2012 | $1.21M | +396.1% |
| 2011 | -$409.0K | +86.2% |
| 2010 | -$2.96M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.01M | -27.4% | +43.3% |
| June 30, 2025 | -$47.63M | -117.1% | -71.2% |
| March 31, 2025 | -$27.82M | +9.0% | -31.3% |
| September 30, 2024 | -$21.20M | +12.4% | +3.4% |
| June 30, 2024 | -$21.94M | +26.6% | +28.2% |
| March 31, 2024 | -$30.57M | +12.8% | -26.3% |
| September 30, 2023 | -$24.20M | +38.8% | +19.1% |
| June 30, 2023 | -$29.89M | +24.7% | +14.8% |
- NEOGENOMICS INC showed a decrease of -25.8% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, NEOGENOMICS INC’s operating income has declined by 3810.9% (from -$2.96 million to -$115.88 million).
- The most recent figure is from NEOGENOMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: